Caveolins in cardioprotection - translatability and mechanisms - Wikidata - wikimedia - TriplyDB

Caveolins in cardioprotection - translatability and mechanisms

Caveolins in cardioprotection - translatability and mechanisms

http://www.wikidata.org/entity/Q35286413

about

Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Caveolins and caveolae in ocular physiology and pathophysiology.Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology.'Conditioning the heart' - lessons we have learned from the past and future perspectives for new and old conditioning 'drugs'.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.The effects of aging on the regulation of t-tubular ICa by caveolin in mouse ventricular myocytes.Cavin-1 deficiency modifies myocardial and coronary function, stretch responses and ischaemic tolerance: roles of NOS over-activity.Conditioning-induced cardioprotection: Aging as a confounding factor

P2860

Q38855645-D6340655-EB69-41E5-B35B-5FC667C14D9D Q38903618-36E55846-D25F-4FB3-9D5C-6156878DB7C2 Q38963501-AF9C4FC5-B42C-4761-A972-9D6A80B0D2FD Q39103381-DC5DEAC0-EE86-40B3-953F-C1B23004A5BA Q43219124-B6E1A68A-CFC1-450D-B8CF-5B5B047B6EC8 Q46034115-D5CCC5B2-617C-4595-8001-47A41059EE9A Q46118931-690045F0-34F3-4CC1-BF24-7231AA7F87FE Q48245190-1DFA4981-E7D3-4C05-949E-5E4615DEA7BF Q58700982-2DC7D0CF-9C9A-41BD-881A-B5F508B12C26

P2860

Caveolins in cardioprotection - translatability and mechanisms

http://www.wikidata.org/entity/Q35286413

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Caveolins in cardioprotection - translatability and mechanisms

@ast

Caveolins in cardioprotection - translatability and mechanisms

@en

type

label

Caveolins in cardioprotection - translatability and mechanisms

@ast

Caveolins in cardioprotection - translatability and mechanisms

@en

prefLabel

Caveolins in cardioprotection - translatability and mechanisms

@ast

Caveolins in cardioprotection - translatability and mechanisms

@en

P1433

Q35286413-F98AC541-A355-463E-B45B-FEBE287BC459

P1476

Q35286413-B7988BFF-BA0C-44A2-81E2-52106698F31A

P2093

Q35286413-062FD482-3321-4EE9-99E4-6200213A8177

Q35286413-C276857A-3063-4DB4-9C39-1EFB3ADDE6F5

Q35286413-ECE2706F-307C-46A2-BDAE-191507FE5694

P2860

Q35286413-0136FC4A-490A-4808-9194-CC656D9C271F

Q35286413-01459593-1189-4BAD-8730-76F11DC2A17E

Q35286413-06049A7D-2BE4-4A1B-BE06-B6315284770F

Q35286413-0891B343-47C2-43C3-B744-6BFBBC630CA6

Q35286413-0D7F99F9-81CD-4487-8E80-F5E7ACD8C84A

Q35286413-0DBE00FD-F664-4718-93E9-6F498446D597

Q35286413-12FEBDEB-4904-407C-AC96-313CCEE37271

Q35286413-139170F9-CCC1-4DB3-93AE-D7E355B51477

Q35286413-13A44F33-1521-438D-8483-1A921BDCD2CF

Q35286413-14591F8D-9F19-4903-801D-42D0E99A7057

P304

Q35286413-E17C99D3-779E-47A9-B34B-52929B2C75ED

P31

Q35286413-6BD431E9-5231-407F-BF3E-A1F10E441F07

P356

Q35286413-3BE13808-65ED-4852-B544-F86B156EABC9

P407

Q35286413-AAA5DFDE-77B0-4492-A64A-B7E0C22E878E

P433

Q35286413-246311D2-5D67-4D99-AE48-7F2BF8C752AC

P478

Q35286413-B872B08D-A9A7-4CEA-8F8C-116299327740

P577

Q35286413-837F5896-2084-49CE-8E88-F7E3E2E85D46

P698

Q35286413-394AC4F6-BDD8-4994-9F01-0AC67CDA3D5F

P932

Q35286413-8B4CAF04-8CC6-4B47-8130-FF00522F703E

P356

P1433

British Journal of Pharmacology

P1476

Caveolins in cardioprotection - translatability and mechanisms

@en

P2093

David M Roth

http://www.w3.org/2001/XMLSchema#string

Hemal H Patel

http://www.w3.org/2001/XMLSchema#string

Jan M Schilling

http://www.w3.org/2001/XMLSchema#string

P2860

The caveolin proteins

Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome

Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology

Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo

Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning

Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis

Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Caveolin-3 deficiency causes muscle degeneration in mice

Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy

P304

2114-2125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13009

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25377989

http://www.w3.org/2001/XMLSchema#string

P932

4386985

http://www.w3.org/2001/XMLSchema#string